50.3 🩺 內科專科考前版

50.3.0.1 📌 䞀頁重點

  • 22E: cancer cachexia 認可、anamorelin / olanzapine for cancer cachexia
  • Taiwan: 食道癌、胃癌、肝癌 高 prevalence
  • Long COVID weight loss

50.3.0.2 💊 治療

50.3.0.2.1 Cancer Cachexia
  • Multidisciplinary
  • Anamorelin (ghrelin agonist) — Japan, EU
  • Olanzapine 改善 食慟
  • Megestrol limited evidence
  • Resistance training + nutrition
50.3.0.2.2 Frailty / Sarcopenia
  • Geriatric assessment
  • Resistance training
  • Vit D + protein

50.3.0.3 🌟 Pearls (5)

  1. Cancer cachexia anamorelin / olanzapine
  2. Frailty + sarcopenia in elderly = falls + mortality risk
  3. Functional dysphagia in elderly can mask cancer
  4. HCC in HBV screening
  5. GI bleeding chronic → IDA → CRC

50.3.0.4 📍 Taiwan Context

  • 胃癌 / 倧腞 / 肝 / 肺 / 食道 高
  • 健保 cancer screening
  • Frailty assessment 掚廣

50.3.0.5 🎓 內專重點

  1. 4 病因
  2. Workup standard
  3. Cancer cachexia
  4. Frailty / sarcopenia
  5. Apathetic hyperthyroidism

⚠ AI 草皿。